Wednesday , September 28 2022

Canadian principal researcher, pioneer of the Canadian Proyective Cohort Study, people living with MS (CanProCo)



[ad_1]








The world leader in MS researchers, led by Dr. Jiwon Oh, select to start work
Canadian cohorts to study multiple progressive sclerosis progression

TORONTO, December 6, 2018 / CNW / – The Canadian Multiple Sclerosis Association and the Brain Canada Foundation have announced today that the Canadian cohort has been announced to advance multiple sclerosis (MS). Dr. Jiwon Ohbased on San Miguel A group of 50 leading researchers from a variety of multidisciplinary centers in the country has selected a $ 7 + million Canadian Proactive Cohort Study for MS (CanProCo). Financing pair Brain Canada She receives Canadian Healthcare funding through the Canadian Brain Research Fund. Biogen Canada is a co-founder and financier of the project, providing support from the beginning.

Dr. Oh, Ph.D., neurologists and researchers are developing research into the development of advanced techniques of Advanced Magnetic Resonance Imaging (MRI). Degree in Law at the Queen's University, PhD and clinical grant Johns Hopkins Medical SchoolOh Dr. is continuing the research effort he has committed to commit suicide. Multiple Sclerosis Cooperative North American Images, and MRI research centers.

"We are glittering. Jiwon Oh and its team promotes this unique project, and answers some confusing questions about MS. " Pamela Valentine, president and CEO, MS Society of Canada. "As an MS research leader, Dr. Oh has dedicated his career to finding out about this disease and finding a cure. The team that collaborates in this project has a rich knowledge of the table, with the help of our experience and with our funding partners, Biogen and Brain Canada, this group has the potential to live with tens of thousands of Canadian Canadians. "

"It is one of the highest rates in the Canadian world, so it is essential that we learn more about this disease and how it progresses," said Dr. Oh. "If we achieve a better understanding of MS progression, we can have a great impact on improving the quality of life of many people who manage the disease and on many Canadians."

CanProCo is the first project of this kind In Canada to understand the unknown nature of the disease progression. Because some people do not understand their disease and some people are moving forward, the researchers will also be able to advance and manage some of the methods to manage them, as well as to measure the negative impact on people, as well as the Canadian health system. .

Dr. Oh, also, the group's main researchers are: Dr. Shannon Kolind (British Columbia University), Dr. Larry Lynd (British Columbia University), Dr. Scott Patten (Calgary University), Dr. Alexandre Prat (Centro de Recherche du CHUM), Dr. Roger Tam (British Columbia University), and PhD Anthony Traboulsee (British Columbia University).

Can DrKoCo, Dr. Oh and his team, will be able to collect and analyze Canadian data residing with MS for biological, physical, and socioeconomic factors to better understand each person's unique experiences and get information on progress. . Using data from cohort, the researchers hope to avoid diagnosis, treatment and illness. The results of the research have the potential to affect how MS live with MS and talk about the progress of MS.

Long-track monitoring of MS helps build a centralized and open source data source. Not only do MS researchers, but also other neurodegenerative diseases, such as Alzheimer's, Parkinson's, Amyotrophic lateral disorder, and Huntington, due to the potential mechanisms of common illnesses.

The recruitment of people taking part in this study will begin at the beginning of 2019. Click on it here For more information on Canada's MS Progress Cohort.

Canadian Proactive Cohort Examination Background People living with MS (CanProCo)

Progression – or the stability of serious illnesses and the increase in disability – is a real reality before MS caused by MS, and despite the progress of MS research, the progressive mechanism and the ways in which the progress of researchers and doctors are still unfulfilled. to fully understand CanProCo can have significant implications for how those who are diagnosed with MS are diagnosed and manage and understand disease in several stages of the disease. This study will move forward from biological, physical and socioeconomic perspectives, and for example, people living with MS will capture their individual experiences. After all, the goal of the cohort is to link biological discoveries with the real world and clinical findings to create an overview of the progress of MS, as researchers will be able to better understand the unknown nature of MS and find cure.

This Canadian $ 7 million investment in Canadian research is supported by founding partners. Thanks to the MS Society, PCL Construction and Bennett Jones LLP have been generous support $ 1.25 million and $ 1 million, respectively, as well as several people who have made significant contributions.

Multiple sclerosis and the Canadian MS Society

Canada is one of the largest rates of multiple sclerosis in the world, diagnosed with more than 11 people. MS is a chronic disease of the central nervous system that is between the brain, the spinal cord and the optic nerve. People with MS have a diagnosis of 15 to 40 years old and do not predict the effects of the disease for the rest of their lives. MS Society offers programs and services aimed at MS and its families, supportive of MS living and subsidized research, to improve the quality of life of those living with MS and, ultimately, to cure this illness. Visit mssociety.ca or call 1-800-268-7582 or donate for more information. Join in the conversation and connect to the MS community online. Find the MS Society Twitter, Instagram or you like our page on Facebook.

About Brain Canada and the Canadian Brain Research Fund

Brain Canada It is a nationally registered charity association Montreal, which enables and recognizes the versatile and excellent, innovative and variable paradigm of brain research In Canada. Since 1998, Brain Canada The brain's case in a neurological brain, mental illnesses and addictions, like a single and complex system of brain and spinal injuries. As it develops in the brain, it emphasizes the need for greater collaboration between disciplines and institutions, and the most effective way to invest in brain research is the benefit of patients and families. Brain Canada The vision is to understand the brain, health and illness, to improve life and achieve social impact.

Canadian Brain Research Fund is Canada's Government and public-private partnership Brain CanadaCanadians were designed to increase brain research support and maximize the impact and effectiveness of these investments. Brain Canada Committed to it $ 115 million From private donors and non-federated partners, now more than 100, including Health Canada $ 120 million. For more information, visit www.braincanada.ca or continue with us Twitter or Facebook.

SOURCE, Canadian Multiple Sclerosis Association

For more information: Media contacts: Jennifer Asselin, MS Society of Canada, 1-800-268-7582. 3144, [email protected]; Michael Oliveira, San Miguel Hospital, 416-864-5047, [email protected]

Related link
http://www.mssociety.ca

[ad_2]
Source link